With box warnings

Without box warnings

Branded

Generic

3 results

decitabine
(Decitabine)
Meitheal Pharmaceuticals Inc.
Usage: Decitabine for Injection is indicated for the treatment of adult patients with myelodysplastic syndromes (MDS), including various subtypes and risk groups, both previously treated and untreated, de novo and secondary MDS.
revlimid
(Lenalidomide)
Celgene Corporation
Usage: REVLIMID is indicated for adult patients with multiple myeloma (MM), myelodysplastic syndromes (MDS), mantle cell lymphoma (MCL), follicular lymphoma (FL), and marginal zone lymphoma (MZL). It is used in combination with dexamethasone, rituximab products, or as maintenance therapy post-transplant. Not recommended for chronic lymphocytic leukemia (CLL).
rytelo
(imetelstat sodium)
Geron Corporation
Usage: RYTELO is indicated for treating adult patients with low- to intermediate-1 risk myelodysplastic syndromes (MDS) who have transfusion-dependent anemia (requiring 4+ red blood cell units over 8 weeks) and have not responded to or are ineligible for erythropoiesis-stimulating agents (ESA).

Medications for Myelodysplastic Syndrome

decitabine